Matching-Adjusted Indirect Comparison (Maic) Of Pelabresib (Cpi-0610) In Combination With Ruxolitinib Vs Ruxolitinib Or Fedratinib Monotherapy In Patients With Intermediate Or High-Risk Myelofibrosis
Pelabresib;Ruxolitinib;Fedratinib;Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Matching-Adjusted Indirect Comparison (Maic) Of Pelabresib (Cpi-0610) In Combination With Ruxolitinib Vs Ruxolitinib Or Fedratinib Monotherapy In Patients With Intermediate Or High-Risk Myelofibrosis ### Output: Pelabresib;Ruxolitinib;Fedratinib;Ruxolitinib